CA1052694A - Procede d'extraction des entigenes de schistosomes, agent contenant ces antigenes et utilisation de celui-ci - Google Patents

Procede d'extraction des entigenes de schistosomes, agent contenant ces antigenes et utilisation de celui-ci

Info

Publication number
CA1052694A
CA1052694A CA225,850A CA225850A CA1052694A CA 1052694 A CA1052694 A CA 1052694A CA 225850 A CA225850 A CA 225850A CA 1052694 A CA1052694 A CA 1052694A
Authority
CA
Canada
Prior art keywords
antigens
schistosomes
solution
aqueous
bilharziosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA225,850A
Other languages
English (en)
Other versions
CA225850S (en
Inventor
Burkhard Enders
Gunter Henke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of CA1052694A publication Critical patent/CA1052694A/fr
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA225,850A 1974-04-29 1975-04-28 Procede d'extraction des entigenes de schistosomes, agent contenant ces antigenes et utilisation de celui-ci Expired CA1052694A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2420706A DE2420706C3 (de) 1974-04-29 1974-04-29 Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel

Publications (1)

Publication Number Publication Date
CA1052694A true CA1052694A (fr) 1979-04-17

Family

ID=5914244

Family Applications (1)

Application Number Title Priority Date Filing Date
CA225,850A Expired CA1052694A (fr) 1974-04-29 1975-04-28 Procede d'extraction des entigenes de schistosomes, agent contenant ces antigenes et utilisation de celui-ci

Country Status (16)

Country Link
JP (1) JPS50145518A (fr)
AT (1) AT344329B (fr)
BE (1) BE828565A (fr)
CA (1) CA1052694A (fr)
CH (1) CH617775A5 (fr)
DE (1) DE2420706C3 (fr)
DK (1) DK140044C (fr)
EG (1) EG12734A (fr)
ES (1) ES436866A1 (fr)
FR (1) FR2268532B1 (fr)
GB (1) GB1478082A (fr)
IE (1) IE41024B1 (fr)
IT (1) IT1049537B (fr)
LU (1) LU72375A1 (fr)
NL (1) NL7504853A (fr)
ZA (1) ZA752717B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356428A1 (fr) * 1976-06-29 1978-01-27 Inserm Ctre Technologie Biomed Procede de preparation d'un agent immunologique antiparasitaire, produit obtenu et son application
FR2601037B1 (fr) * 1986-07-03 1988-10-21 Pasteur Institut Peptide presentant des proprietes antigeniques isole de la proteine 28 kd de s. mansoni et son procede d'isolement, anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et application de celui-ci dans l'induction de la synthese d'anticorps neutralisants
CN117203526A (zh) * 2020-10-27 2023-12-08 默克专利有限公司 用于检测血吸虫感染的蛋白质

Also Published As

Publication number Publication date
GB1478082A (en) 1977-06-29
DE2420706C3 (de) 1979-11-22
FR2268532A1 (fr) 1975-11-21
ATA325475A (de) 1977-11-15
NL7504853A (nl) 1975-10-31
EG12734A (en) 1979-06-30
DK140044C (da) 1979-11-12
IE41024L (en) 1975-10-29
JPS50145518A (fr) 1975-11-21
BE828565A (fr) 1975-10-29
ZA752717B (en) 1976-03-31
DE2420706B2 (de) 1979-03-22
IE41024B1 (en) 1979-10-10
AT344329B (de) 1978-07-10
CH617775A5 (en) 1980-06-13
DK140044B (da) 1979-06-11
DE2420706A1 (de) 1975-10-30
FR2268532B1 (fr) 1980-01-25
ES436866A1 (es) 1977-01-01
DK184575A (da) 1975-10-30
IT1049537B (it) 1981-02-10
LU72375A1 (fr) 1977-02-03

Similar Documents

Publication Publication Date Title
Feigin et al. Human leptospirosis
Wells Chemical pathology
Zuckerman et al. Hepatitis viruses of man
Kennedy et al. The secreted and somatic antigens of the third stage larva of Anisakis simplex, and antigenic relationship with Ascaris suum, Ascaris lumbricoides, and Toxocara canis
Smyth The biology of the hydatid organisms
Jasin et al. Relationship between soluble collagen and urinary hydroxyproline in the lathyritic rat.
Mills et al. Excretions and secretions of Trichinella spiralis and their role in immunity
Foxall et al. Effects of a hepatic toxin from the cyanophyte Microcystis aeruginosa
Seibert et al. The isolation and chemistry of a protein fraction of M. tuberculosis and its ability to sensitize cells
Sharp et al. Hypersensitivity responses in Toxocara-, Ascaris-, and Trichinella-infected guinea pigs to homologous and heterologous challenge
Tabatabai et al. Isolation and characterization of toxic fractions from Brucella abortus
Maizels et al. Secreted and surface antigens from larval stages of Wuchereria bancrofti, the major human lymphatic filarial parasite
CA1052694A (fr) Procede d'extraction des entigenes de schistosomes, agent contenant ces antigenes et utilisation de celui-ci
US4150107A (en) Antigen from schistosomes and process for obtaining same
Rathlev Evaluation of the sorbents used in the FTA-ABS test
Smith et al. Comparative assessment of a double antibody enzyme immunoassay test kit and a triple antibody enzyme immunoassay for the diagnosis of Trichinella spiralis spiralis and Trichinella spiralis nativa infections in swine
Sutherland THE SYDNEY FUNNEL–WEB SPIDER (ATRAX ROBUSTUS) 2. FRACTIONATION OF THE FEMALE VENOM INTO FIVE DISTINCT COMPONENTS
Dutta et al. The effect of gastrointestinal enzymes on cholera toxin
Heller et al. Antigenicity of connective tissue extracts.
GB1603189A (en) Peptide complexes of desoxyribonucleic acid (dna) obtained from dna-containing organisms
Boulanger et al. Fluorescein-labelled antibody technique for the demonstration of Leptospira pomona
Pugh Jr et al. The pathophysiological effects of Moraxella bovis toxins on cattle, mice and guinea pigs
Nakajima et al. Preparation of equine infectious anemia virus antigen for immunodiffusion test
Ruiz-Bravo et al. Immunolocalization of the sea urchin sperm receptor in eggs and maturing ovaries
Min et al. Elevation of specific IgE antibody in Clonorchis sinensis infection